ONWARD Medical Schedules Q1 2026 Earnings Call Amid ARC-IM Development
Event summary
- ONWARD Medical will release Q1 2026 financial results on May 26, 2026.
- CEO Dave Marver will host the earnings webcast at 2:00 PM CEST / 8:00 AM EDT.
- Company's ARC-EX® System is commercially available in the US and Europe.
- ARC-IM® implantable system remains investigational, targeting blood pressure instability post-SCI.
The big picture
ONWARD Medical's Q1 2026 earnings call comes as the company balances commercializing its ARC-EX system with developing the investigational ARC-IM. The strategic focus on restoring movement in spinal cord injury patients positions ONWARD at the forefront of neurotechnology, though success hinges on regulatory approvals and technological advancements. The company's ability to scale its solutions will be critical in a competitive medical device market.
What we're watching
- Regulatory Progress
- The pace at which ARC-IM advances from investigational to commercial use, particularly given its FDA Breakthrough Device Designations.
- Revenue Growth
- Whether ARC-EX commercialization can drive meaningful revenue growth in Q1 2026.
- Technological Integration
- How ONWARD Medical integrates AI and BCI with its implantable systems to enhance thought-driven movement restoration.
Related topics